SCHEMBL1412935

SCHEMBL1412935

[CH2]C(C)CCC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9720153 0.82 ALDH1A1 (0.53)
SCHEMBL6179882 0.78
SCHEMBL35996 0.77
SCHEMBL7617473 0.77
SCHEMBL3790342 0.77 CA1 (0.57)
SCHEMBL7541851 0.77
SCHEMBL28655640 0.76
SCHEMBL842034 0.74
SCHEMBL14997347 0.74
SCHEMBL15091902 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8361753-B2 Phosphotriester-modified oligonucleotide primers for nucleic acid amplification TRILINK BIOTECHNOLOGIES, INC. (US) 2013-01-29 US claimed
EP-2032714-B1 CHEMICALLY MODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TRILINK BIOTECHNOLOGIES (US) 2011-03-16 EP claimed
EP-2032714-A1 CHEMICALLY MODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TriLink BioTechnologies (US) 2009-03-11 EP claimed
WO-2007139723-A1 CHEMICALLYMODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TRILINK BIOTECHNOLOGIES (US) 2007-12-06 WO claimed
US-20070281308-A1 CHEMICALLY MODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TRILINK BIOTECHNOLOGIES, LLC 2007-12-06 US claimed
EP-3842550-A1 METHOD FOR ANALYZING FUNCTIONAL SUBUNIT PAIR GENE OF T CELL RECEPTOR AND B CELL RECEPTOR Repertoire Genesis Incorporation (JP) 2021-06-30 EP disclosed
WO-2020040302-A1 METHOD FOR ANALYZING FUNCTIONAL SUBUNIT PAIR GENE OF T CELL RECEPTOR AND B CELL RECEPTOR Repertoire Genesis株式会社 2020-02-27 WO disclosed
EP-3486321-A1 T-CELL RECEPTOR AND B-CELL RECEPTOR REPERTOIRE ANALYSIS SYSTEM USING ONE-STEP REVERSE TRANSCRIPTION TEMPLATE-SWITCHING PCR Riken (JP) 2019-05-22 EP disclosed
EP-3476944-A1 ONE-STEP REVERSE TRANSCRIPTION TEMPLATE-SWITCHING PCR Riken (JP) 2019-05-01 EP disclosed
EP-2032714-B1 CHEMICALLY MODIFIED OLIGONUCLEOTIDE PRIMERS FOR NUCLEIC ACID AMPLIFICATION TRILINK BIOTECHNOLOGIES (US) 2011-03-16 EP disclosed